- Areas of Parctice
-
Dr. Ke Mou joined Liu, Shen & Associates in 2010, and is currently a partner, attorney at law, and patent attorney. Dr. Mou is experienced in global protection strategy, patent drafting, portfolio management, legal consulting, due diligence, and dispute resolution of patents, as well as the management and protection of trade secret. Dr. Mou has a good scientific background in the pharmaceutical industry and legal knowledge in IP related laws and regulations, fully understanding the business strategy, scientific development, and legal protection of the pharmaceutical products.
Dr. Mou has in-depth understanding of Patent Term Adjustment (PTA) and Patent Term Extension (PTE), and has provided application and litigation services on PTA and PTE to several domestic and foreign companies.
Dr. Mou obtained the qualification as a patent attorney in 2012, and qualification as attorney at law in 2015.
- Education and Trainning
-
- 2015-2017The John Marshall Law School, L.L.M. in Intellectual Property Law (with honors)
- 2004-2010 Peking University, Ph.D. in Medicinal Chemistry
- 2000-2004Peking University, Bachelor in Pharmaceutical Science
- Repreaentative Cases
-
- Provided services on patent listings and PTA/PTE applications for several domestic and multi-national pharmaceutical companies (2021-)
- Supported a strategic collaboration between a Beijing-based innovative pharmaceutical company and a leading UK pharmaceutical company (2025)
- Conducted FTO analysis for a Beijing-based pharmaceutical company (2025)
- Represented an Irish company as the patentee in two invalidation cases (2024)
- Provided FTO analysis services for a UK-based pharmaceutical company on licensing-in a new drug from a domestic company (2024)
- Conducted FTO analysis for a Beijing-based pharmaceutical company for patent licensing (2024)
- Performed patentability analysis on a target patent for a German pharmaceutical company (2024)
- Provided legal consulting services to a Japanese multi-national company (including infringement assessment, Bolar exception, and patent invalidity analysis) (2022-2024)
- Assisted a Wuxi-based pharmaceutical company in cross-border financing due diligence (2023)
- Supported a Beijing-based biotech company in financing due diligence (2023)
- Conducted FTO analysis for a contraceptive drug on behalf of a client (2023)
- Performed patentability analysis on a patent for a Guangzhou-based technology company (2023)
- Conducted FTO analysis for a Beijing-based pharmaceutical company (2022)
- Provided FTO analysis services for a Beijing-based biotechnology company (2021)
- Invalidated a disputed patent on behalf of a multi-national pharmaceutical company in a dispute with its distributor (2020–2021)
- Provided legal advice to a Suzhou-based pharmaceutical company on licensing-in a new drug from a U.S. firm (2020)
- Conducted due diligence for a domestic life sciences group investing in a technology company (2020)
- Conducted generic drug market entry analysis for a Shenzhen-based company (2020)
- Participated in an arbitration case involving a contract dispute between a pharmaceutical company and a U.S. firm (2020)
- Publications and Speeches
-
- Delivered a speech at the "2025 Biopharma and Healthcare Industry Global Expansion Strategy Practical Training" hosted by the Zhongguancun Social Organization Federation (2025)
- Delivered a speech at the event by Beijing Intellectual Property Public Service Center: Overseas Patent Portfolio Strategy and Dispute Resolution (2024)
- Served as Moderator at China UPC Roadshow (co-organized by Liu Shen, and Bardehle Pagenberg) (2024)
- Delivered a speech at 5th BIONNOVA Biopharma Innovators Summit & Expo (2023)
- Served as panelist at Enforcement of Trade Secrets: The Practical Realities (AIPPI 2020 World Congress)
- The Management and Protection of Trade Secret Assets from the Perspective of Business Competition (2020)
- Trade Secret Protection: Implementing Reasonable Confidentiality Measures (2020)
- Awards
-
- Appointed as an Expert for Overseas Intellectual Property Rights Protection in Hebei Province
- Recognized for a National Exemplary Invention Patent Drafting Case (the only small-molecule drug patent case selected)
- Included in the Beijing Lawyers Association’s Directory of Foreign-Related Legal Talent
- Members
-
All-China Patent Agents Association (ACPAA)
All-China Lawyers Association (ACLA)
International Association for the Protection of Intellectual Property (AIPPI)
